Pain

Implementing a Health Policy Intervention to Improve Access to Pain Relief for Patients with Cancer in Africa

Citation:

Martha A. Maurer; Virginia T. LeBaron; Aaron M. Gilson; Emmanuel Luyirika Fatia Kiyange; Henry Ddungu;  James F. Cleary, MD. Poster presented at the 8th Annual Conference on the Science of Dissemination & Implementation Research in Health, December 14-15, 2015 Washington, D.C.

Abstract:
Author: 

Martha A. Maurer; Virginia T. LeBaron; Aaron M. Gilson; Emmanuel Luyirika Fatia Kiyange; Henry Ddungu;  James F. Cleary, MD. Poster presented at the 8th Annual Conference on the Science of Dissemination & Implementation Research in Health, December 14-15, 2015 Washington, D.C.

Examining Influences on the Availability of and Access to Opioids for Pain Management and Palliative Care

Citation:

Maurer MA, Gilson AM, Husain SA, Cleary JF. Examining the Influences on the Availability of and Access to Opioids for Pain Management and Palliative Care. Journal of Pain & Palliative Care Pharmacotherapy. 2013; 27:255-260. 

Abstract:
Author: 

Maurer MA, Gilson AM, Husain SA, Cleary JF. Examining the Influences on the Availability of and Access to Opioids for Pain Management and Palliative Care. Journal of Pain & Palliative Care Pharmacotherapy. 2013; 27:255-260. 

Abstract

State medical board members' beliefs about pain, addiction, and diversion and abuse: A changing regulatory environment

Citation:

Gilson AM, Maurer MA, Joranson DE. State medical board members' beliefs about pain, addiction, and diversion and abuse: A changing regulatory environment. Journal of Pain 2007;8:682-691.

 

Abstract:
Author: 

Gilson AM, Maurer MA, Joranson DE. State medical board members' beliefs about pain, addiction, and diversion and abuse: A changing regulatory environment. Journal of Pain 2007;8:682-691.

 

Three national surveys were conducted in 1991, 1997, and 2004 to evaluate state medical board members' knowledge and attitudes about prescribing opioid analgesics for pain management. Topics addressed include perceived legality of prolonged opioid prescribing, characteristics of addiction, prevalence of medication abuse and diversion, and perceived importance and influence of medical board policy. Questions were added in 2004 to determine board members' views about law enforcement involvement in physician investigations and prosecutions.

The Federal Drug Enforcement Administration "prescription series" proposal: Continuing concerns

Citation:

Gilson AM, Joranson DE. The Federal Drug Enforcement Administration "prescription series" proposal: Continuing concerns. J Pain Palliat Care Pharmacother 2007;21:21-24.

Abstract:
Author: 

Gilson AM, Joranson DE. The Federal Drug Enforcement Administration "prescription series" proposal: Continuing concerns. J Pain Palliat Care Pharmacother 2007;21:21-24.

Two leading health and pain policy analysts discuss the implications of the federal Drug Enforcement Administration proposed position on the legality of practitioners writing series of controlled substance prescriptions for the purpose of providing ongoing pain management without the necessity for unneeded patient visits to their prescribers. This issue led to a series of regulatory proposals that engendered great concern in the pain management community. The proposed positive outcome from the DEA is described.

Improving state pain policies: Recent progress and continuing opportunities

Citation:

Gilson AM, Joranson DE, Maurer MA. Improving state pain policies: Recent progress and continuing opportunities. CA: A Cancer Journal for Clinicians 2007;57:341-353.

Abstract:
Author: 

Gilson AM, Joranson DE, Maurer MA. Improving state pain policies: Recent progress and continuing opportunities. CA: A Cancer Journal for Clinicians 2007;57:341-353.

No abstract available for this article.

 (PDF)

Interpreting changes in state laws and regulations governing the use of controlled substances to treat pain

Citation:

Gilson AM. Interpreting changes in state laws and regulations governing the use of controlled substances to treat pain. Advances in Pain Management 2007;1:60-66.

Abstract:
Author: 

Gilson AM. Interpreting changes in state laws and regulations governing the use of controlled substances to treat pain. Advances in Pain Management 2007;1:60-66.

No abstract available for this article.

 (PDF)

Do International Model Drug Control Laws Provide for Drug Availability?

Citation:

Pain & Policy Studies Group. Do International Model Drug Control Laws Provide for Drug Availability? J Pain Palliat Care Pharmacother 2009;23:145-152.

Abstract:
Author: 

Pain & Policy Studies Group. Do International Model Drug Control Laws Provide for Drug Availability? J Pain Palliat Care Pharmacother 2009;23:145-152.

A preliminary review of the United Nations Office on Drugs and Crime (UNODC) model drug control laws was conducted by the Pain & Policy Studies Group (PPSG) to determine whether the models provided governments with language they can use to carry out the obligation to ensure adequate availability of opioid analgesics for the relief of pain and suffering, specified in the Single Convention on Narcotic Drugs, 1961 as amended, and as recommended by the International Narcotics Control Board in 1995. The results showed that current model laws lack the drug availability provisions.

Ensuring patient access to essential medicines while minimizing harmful use: A revised WHO tool to improve national drug control policy

Citation:

Gilson AM, Maurer MA, Ryan KM, Skemp-Brown M, Husain A, Cleary JF. Ensuring patient access to essential medicines while minimizing harmful use: A revised WHO tool to improve national drug control policy. J Pain Palliat Care Pharmacother 2011;25:246-251.

Abstract:
Author: 

Gilson AM, Maurer MA, Ryan KM, Skemp-Brown M, Husain A, Cleary JF. Ensuring patient access to essential medicines while minimizing harmful use: A revised WHO tool to improve national drug control policy. J Pain Palliat Care Pharmacother 2011;25:246-251.

In 2011, the World Health Organization (WHO) published a series of 21 guidelines to assist governments in improving their national drug control laws, regulations, and administrative procedures to promote the availability of controlled medicines for pain relief and for a variety of acute and chronic diseases and conditions. These guidelines ultimately are designed to encourage the development of policies designed to fulfill a country's dual obligation concerning these medicines: to prevent their abuse, diversion and trafficking while ensuring access for medical and scientific purposes.

Using a morphine equivalence metric to quantify opioid consumption: Examining the capacity to provide effective treatment of debilitating pain at the global, regional and country levels

Citation:

 

Gilson AM, Maurer MA, Ryan KM, Rathouz PJ, Cleary JF. Using a Morphine Equivalence Metric to Quantify Opioid Consumption: Examining the Capacity to Provide Effective Treatment of Debilitating Pain at the Global, Regional, and Country Levels. J Pain Symptom Manage 2013; 45(4):681-700.
 
Abstract:
Author: 

 

Gilson AM, Maurer MA, Ryan KM, Rathouz PJ, Cleary JF. Using a Morphine Equivalence Metric to Quantify Opioid Consumption: Examining the Capacity to Provide Effective Treatment of Debilitating Pain at the Global, Regional, and Country Levels. J Pain Symptom Manage 2013; 45(4):681-700.
 

Context

Italy reforms national policy for cancer pain relief and opioids

Citation:

Blengini C, Joranson DE, Ryan KM. Italy reforms national policy for cancer pain relief and opioids. Eur J Cancer Care 2003;12:28-34.

Abstract:
Author: 

Blengini C, Joranson DE, Ryan KM. Italy reforms national policy for cancer pain relief and opioids. Eur J Cancer Care 2003;12:28-34.

Treatment of pain caused by cancer in Italy has been reported to be inadequate for more than a decade. The problem has been documented in the literature by International Narcotics Control Board (INCB) reports that show Italy's low consumption of morphine, and by INCB statements reflecting concern that pain medications are not adequately available to suffering cancer patients. The reasons for undertreatment include lack of physician education, low public awareness about pain management and overly restrictive regulations that inhibit the prescribing of opioid analgesics.

Country: 
Syndicate content